Cargando…

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer

Necroptosis is one of the common modes of apoptosis, and it has an intrinsic association with cancer prognosis. However, the role of the necroptosis-related long non-coding RNA LncRNA (NRLncRNAs) in uterine corpora endometrial cancer (UCEC) has not yet been fully elucidated at present. Therefore, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhiheng, Fan, Weisen, Sui, Xiaohui, Wang, Juntao, Zhao, Junde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Gynecologic Oncology: Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988759/ https://www.ncbi.nlm.nih.gov/pubmed/35854199 http://dx.doi.org/10.1007/s43032-022-01023-9

Ejemplares similares

Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas
por: Lin, Zhiheng, et al.
Publicado: (2022)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
por: Lin, Zhiheng, et al.
Publicado: (2022)

Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis
por: Huss, Alexandra, et al.
Publicado: (2022)

A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
por: Song, Chong, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma
por: Zheng, Yixin, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
por: Zhao, Lei, et al.
Publicado: (2023)

Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
por: Travaglino, Antonio, et al.
Publicado: (2022)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
por: Gu, Hongmei, et al.
Publicado: (2022)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis
por: Ni, Liwei, et al.
Publicado: (2019)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Wu, Pengfei, et al.
Publicado: (2022)

Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer
por: Wang, Haixu, et al.
Publicado: (2021)

A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer
por: He, Wei-Peng, et al.
Publicado: (2022)

Necroptosis‐related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer
por: Chen, Fangyue, et al.
Publicado: (2022)

Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study
por: Turan, Hasan, et al.
Publicado: (2022)

Femur metastasis in carcinoma of the uterine cervix: a rare entity
por: Corrado, Giacomo, et al.
Publicado: (2009)

CD44 expression in curettage and postoperative specimens of endometrial cancer
por: Wojciechowski, Michał, et al.
Publicado: (2014)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients
por: Zhang, Yuan, et al.
Publicado: (2022)

The sL1CAM in sera of patients with endometrial and ovarian cancers
por: Wojciechowski, Michał, et al.
Publicado: (2016)

Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer
por: Papadia, Andrea, et al.
Publicado: (2016)

Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia
por: Girbash, Ehab F., et al.
Publicado: (2023)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
por: Li, Pian, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Learning curve for laparoscopic staging of early and locally advanced cervical and endometrial cancer
por: Tahmasbi Rad, Morva, et al.
Publicado: (2013)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Conservative management of uterine adenosarcoma: lessons learned from 20 years of follow-up
por: L’Heveder, Ariadne, et al.
Publicado: (2019)

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma
por: Fujiwara, Kazuko, et al.
Publicado: (2011)

An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
por: Mathews, Cara, et al.
Publicado: (2022)

Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer
por: Xu, Yuhao, et al.
Publicado: (2022)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9unpn00fn8i9tafbh1ses0jmmd